These effects are mediated, at least in part, via TRPV2, and enhance the inductions of tumor cell apoptosis by modulating oxidative stress pathways and stem cell properties in cisplatin-resistant lung cancer cells. This evidence concerns the gene TRPV2 and lung carcinoma.